Enzastaurin for the treatment of cancer

Details for Australian Patent Application No. 2009330492 (hide)

Owner Eli Lilly and Company

Inventors Ganji, Gopinath

Agent Spruson & Ferguson

Pub. Number AU-A-2009330492

PCT Pub. Number WO2010/074936

Priority 61/122,451 15.12.08 US

Filing date 7 December 2009

Wipo publication date 1 July 2010

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/00 (2006.01)

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4545 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/074936 Priority application(s): WO2010/074936

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009330493-Systems and methods for charging an electric vehicle using broadband over powerlines

2009330474-Link and link assembly for track-type machine